Wenjia Su

Landscape of Acquired Resistance to Osimertinib in <i>EGFR</i> -Mutant NSCLC and Clinical Validation of Combined EGFR and RET Inhibition with Osimertinib and BLU-667 for Acquired <i>RET</i> Fusion

Zofia Piotrowska, Hideko Isozaki, Jochen K. Lennerz et al. · Cancer Discovery · 2018 · 445 citations

Medicine, Oncology, Pharmacology +17

Therapy-induced APOBEC3A drives evolution of persistent cancer cells

Hideko Isozaki, Ramin Sakhtemani, Ammal Abbasi et al. · Nature · 2023 · 145 citations · Full text

Medicine, Cancer Biology, Molecular Genetics +12

The dual role of CD70 in B‐cell lymphomagenesis

Man Nie, Weicheng Ren, Xiaofei Ye et al. · Clinical and Translational Medicine · 2022 · 21 citations · Full text

Medicine, Immunology, Oncology +12

APOBEC3A drives acquired resistance to targeted therapies in non-small cell lung cancer

Hideko Isozaki, Ammal Abbasi, Naveed Nikpour et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2021 · 18 citations

Life Sciences, Genetics, Oncology +14

An Immune-Related Gene Prognostic Index for Triple-Negative Breast Cancer Integrates Multiple Aspects of Tumor-Immune Microenvironment

Xiaowei Wang, Wenjia Su, Dabei Tang et al. · Cancers · 2021 · 18 citations · Full text

Medicine, Immunology, Oncology +17